Try our mobile app

General information

Country: UNITED STATES

Sector: Medical Devices

Abbott Laboratories discovers, develops, manufactures, and sells a broad and diversified line of health care products and services. The Company"s products include pharmaceuticals, nutritional, diagnostics, and vascular products. Abbott markets its products worldwide through affiliates and distributors.
Website: abbott.com


  • Pretty weak financial results growth rate 8.9% (average between last period year over year growth for revenue and EBITDA), there is acceleration compared to average historical growth rates (-1.5%)
  • Dividend yield for the last twelve months 1.9%
  • Free cash flow yield 0.9% (LTM)
  • Share price is 36.7% higher than minimum and 12.1% lower than maximum for the last 3 years
  • The company is undervalued by EV / LTM EBITDA multiple compared to target level (24.2x vs
    )
  • Fundamental value created in LTM (estimate)
  • For the last 3 months insiders sold company shares on $0.2 mln (0.000% of cap.)

Key Financials (Download financials)

Ticker: ABT
Share price, USD:  (0.0%)123.255
year average price 128.97  


year start price 114.23 2024-12-21

min close price 111.10 2025-01-15

max close price 140.22 2025-03-03

current price 123.26 2025-12-20
Common stocks: 1 746 881 140

Dividend Yield:  1.9%
FCF Yield LTM: 0.9%
EV / LTM EBITDA: 24.2x
EV / EBITDA annualized: 22.7x
Last revenue growth (y/y):  +6.9%
Last growth of EBITDA (y/y):  +10.9%
Historical revenue growth:  -0.5%
Historical growth of EBITDA:  -2.5%
Target EV / EBITDA (hist percentile):
Express share price potential:
Fundamental value created in LTM:
EV / LTM EBITDA mutiple calculation
Market Cap ($m): 215 312
Net Debt ($m): 5 564
EV (Enterprise Value): 220 876
EBITDA LTM ($m): 9 119
EV / LTM EBITDA: 24.2x
Price to Book: 4.3x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / EBITDA

Potential dynamics

News


2025-12-15zacks.com

Why the Market Dipped But Abbott (ABT) Gained Today

2025-12-15zacks.com

Abbott Gains From Lingo CGM's Expansion on Android Platform

2025-12-14fool.com

Start the New Year Off With Passive Income: 3 Dividend Kings to Buy Now

2025-12-13fool.com

My Top 10 Stocks to Buy for 2026

2025-12-11seekingalpha.com

High-Quality Compounders With Both Pricing Power And Idiosyncratic Growth

2025-12-08zacks.com

Here's Why Abbott (ABT) Fell More Than Broader Market

2025-12-06prnewswire.com

University of Wisconsin Wins Abbott and Big Ten's 'We Give Blood' Competition as Campaign Donations Surge 319%, Helping Save Nearly 250,000 Lives

2025-11-24reuters.com

Abbott issues US device correction for some glucose monitors over faulty readings risk

2025-11-20reuters.com

Abbott bolsters diagnostics portfolio with up to $23 billion buyout of Exact Sciences

2025-11-20prnewswire.com

Abbott to acquire Exact Sciences, a leader in large and fast-growing cancer screening and precision oncology diagnostics segments
More information for subscribed users:
detailed calculation of
Potential and Created Value,
website traffic data